Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Helius Medical Technologies ( (HSDT) ) just unveiled an update.
Helius Medical Technologies is actively pursuing strategic alternatives to enhance shareholder value amid challenges with CMS pricing determinations for its PoNS device. Having engaged B. Riley Securities as an advisor, the company is exploring options like mergers or sales, while also addressing reimbursement issues to better position its innovative neuromodulation therapy in the market.
For a thorough assessment of HSDT stock, go to TipRanks’ Stock Analysis page.